Literature DB >> 10500047

Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells in vitro.

M Hara1, A Matsumori, K Ono, H Kido, M W Hwang, T Miyamoto, A Iwasaki, M Okada, K Nakatani, S Sasayama.   

Abstract

BACKGROUND: Mast cells are multifunctional cells containing various mediators such as cytokines, proteases, and histamine. They are found in the human heart and have been implicated in ventricular hypertrophy and heart failure. However, their roles in pathogenesis of these diseases are unknown. METHODS AND
RESULTS: Cultured cardiomyocytes from neonatal rats were incubated with mast cell granules (MCGs) for 24 hours. The highest concentration of diluted MCGs caused the death of approximately 70% of cardiomyocytes. This cell death was proved to be apoptosis, as quantified by electron microscopy and biochemical criteria. MCG-mediated cytotoxicity was prevented by pretreatment of MCGs with protease inhibitors or a neutralizing antibody against rat mast cell chymase 1 (RMCP 1). RMCP 1 by itself was proved to induce cell death of cardiomyocytes. These results suggest that RMCP 1 contained in MCGs causes the death of cardiomyocytes. In contrast, MCGs induced the proliferation of intramyocardial cells other than myocytes. RMCP 1 was also proved to induce their proliferation.
CONCLUSIONS: Mast cells cause apoptosis of cardiomyocytes and proliferation of other intramyocardial cells via the activity of RMCP 1. Our results suggest that mast cell chymase may play a role in the progression of heart failure, because loss of cardiomyocytes and proliferation of nonmyocardial cells exaggerate its pathophysiology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10500047     DOI: 10.1161/01.cir.100.13.1443

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  25 in total

1.  IGF-1 degradation by mouse mast cell protease 4 promotes cell death and adverse cardiac remodeling days after a myocardial infarction.

Authors:  Thor Tejada; Lin Tan; Rebecca A Torres; John W Calvert; Jonathan P Lambert; Madiha Zaidi; Murtaza Husain; Maria D Berce; Hussain Naib; Gunnar Pejler; Magnus Abrink; Robert M Graham; David J Lefer; Nawazish Naqvi; Ahsan Husain
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-06       Impact factor: 11.205

2.  Deficiency of mouse mast cell protease 4 mitigates cardiac dysfunctions in mice after myocardium infarction.

Authors:  Yunzhe Wang; Cong-Lin Liu; Wenqian Fang; Xian Zhang; Chongzhe Yang; Jie Li; Jing Liu; Galina K Sukhova; Michael F Gurish; Peter Libby; Guo-Ping Shi; Jinying Zhang
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2019-01-11       Impact factor: 5.187

3.  Dual inhibition of cathepsin G and chymase reduces myocyte death and improves cardiac remodeling after myocardial ischemia reperfusion injury.

Authors:  Bahman Hooshdaran; Mikhail A Kolpakov; Xinji Guo; Sonni A Miller; Tao Wang; Douglas G Tilley; Khadija Rafiq; Abdelkarim Sabri
Journal:  Basic Res Cardiol       Date:  2017-09-14       Impact factor: 17.165

Review 4.  The multiple mechanistic faces of a pure volume overload: implications for therapy.

Authors:  Justin Barnes; Louis J DellʼItalia
Journal:  Am J Med Sci       Date:  2014-10       Impact factor: 2.378

5.  Accelerated cardiomyocyte senescence contributes to late-onset doxorubicin-induced cardiotoxicity.

Authors:  Maria A Mitry; Dimitri Laurent; Britny L Keith; Elizabeth Sira; Carol A Eisenberg; Leonard M Eisenberg; Sachindra Joshi; Sachin Gupte; John G Edwards
Journal:  Am J Physiol Cell Physiol       Date:  2020-01-08       Impact factor: 4.249

6.  Cyclic stretch of embryonic cardiomyocytes increases proliferation, growth, and expression while repressing Tgf-β signaling.

Authors:  Indroneal Banerjee; Katrina Carrion; Ricardo Serrano; Jeffrey Dyo; Roman Sasik; Sean Lund; Erik Willems; Seema Aceves; Rudolph Meili; Mark Mercola; Ju Chen; Alexander Zambon; Gary Hardiman; Taylor A Doherty; Stephan Lange; Juan C del Álamo; Vishal Nigam
Journal:  J Mol Cell Cardiol       Date:  2014-11-13       Impact factor: 5.000

7.  Lessons learned from experimental myocarditis.

Authors:  A Matsumori
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

8.  Cetirizine a histamine H1 receptor antagonist improves viral myocarditis.

Authors:  Akira Matsumori; Kanjo Yamamoto; Miho Shimada
Journal:  J Inflamm (Lond)       Date:  2010-08-04       Impact factor: 4.981

Review 9.  Dilated cardiomyopathy update: infectious-immune theory revisited.

Authors:  Chuichi Kawai; Akira Matsumori
Journal:  Heart Fail Rev       Date:  2013-11       Impact factor: 4.214

10.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.